Skip to main content
. 2014 Sep 24;16(5):434. doi: 10.1186/s13075-014-0434-z

Figure 4.

Figure 4

Baseline CXCL13 stratified by clinical disease activity score (+/−DAS28-remission) after 2 years of therapy. Both treatment groups are considered together. Bars represent median with IQR. *Indicates statistically significant difference (P = 0.03). CXCR13: C-X-C chemokine receptor type 13; DAS28: disease activity score in 28 joints; IQR: interquartile range.